Sirio Pharma Dividends and Buybacks
Dividend criteria checks 3/6
Sirio Pharma is a dividend paying company with a current yield of 2.97% that is well covered by earnings.
Key information
3.0%
Dividend yield
0.2%
Buyback Yield
| Total Shareholder Yield | 3.2% |
| Future Dividend Yield | 3.2% |
| Dividend Growth | 36.6% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CN¥0.846 |
| Payout ratio | 59% |
Recent dividend and buyback updates
Recent updates
When Should You Buy Sirio Pharma Co., Ltd. (SZSE:300791)?
Dec 13
Is Now The Time To Put Sirio Pharma (SZSE:300791) On Your Watchlist?
Oct 14The Market Lifts Sirio Pharma Co., Ltd. (SZSE:300791) Shares 27% But It Can Do More
Sep 30Is Sirio Pharma (SZSE:300791) Using Too Much Debt?
Sep 23Sirio Pharma Co., Ltd.'s (SZSE:300791) Prospects Need A Boost To Lift Shares
Aug 01Sirio Pharma (SZSE:300791) Will Be Hoping To Turn Its Returns On Capital Around
Jun 30Is Sirio Pharma (SZSE:300791) A Risky Investment?
Jun 12An Intrinsic Calculation For Sirio Pharma Co., Ltd. (SZSE:300791) Suggests It's 24% Undervalued
Apr 24Sirio Pharma (SZSE:300791) Seems To Use Debt Quite Sensibly
Mar 06Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, 300791 has been paying a dividend for less than 10 years.
Growing Dividend: 300791's dividend payments have increased, but the company has only paid a dividend for 5 years.
Dividend Yield vs Market
| Sirio Pharma Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (300791) | 3.0% |
| Market Bottom 25% (CN) | 0.5% |
| Market Top 25% (CN) | 2.1% |
| Industry Average (Personal Products) | 2.4% |
| Analyst forecast (300791) (up to 3 years) | 3.2% |
Notable Dividend: 300791's dividend (2.97%) is higher than the bottom 25% of dividend payers in the CN market (0.54%).
High Dividend: 300791's dividend (2.97%) is in the top 25% of dividend payers in the CN market (2.07%)
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (58.9%), 300791's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: 300791 is paying a dividend but the company has no free cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 08:31 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Sirio Pharma Co., Ltd. is covered by 10 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jing Huang | Chasing Securities |
| Wenbo Chen | China International Capital Corporation Limited |
| Wendan Wang | China International Capital Corporation Limited |